$489.2 Million Worldwide Helicobacter Pylori Diagnostics Industry to 2027 - Impact of COVID-19 on the Market - ResearchAndMarkets.com

DUBLIN--()--The "Helicobacter Pylori Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The publisher brings years of research experience to the 5th edition of this report. The 278-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global Helicobacter Pylori Diagnostics Market to Reach $729.2 Million by 2027

Amid the COVID-19 crisis, the global market for Helicobacter Pylori Diagnostics estimated at US$489.2 Million in the year 2020, is projected to reach a revised size of US$729.2 Million by 2027, growing at a CAGR of 5.9% over the period 2020-2027.

Invasive, one of the segments analyzed in the report, is projected to record 5.4% CAGR and reach US$341.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Invasive segment is readjusted to a revised 6.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $132.5 Million, While China is Forecast to Grow at 8.9% CAGR

The Helicobacter Pylori Diagnostics market in the U.S. is estimated at US$132.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$153.3 Million by the year 2027 trailing a CAGR of 8.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Competitors identified in this market include, among others:

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • DiaSorin SpA
  • Exalenz Bioscience Ltd.
  • F. Hoffmann-La Roche AG
  • Halyard Health, Inc.
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Helicobacter Pylori Diagnostics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 44

For more information about this report visit https://www.researchandmarkets.com/r/8vz1am

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900